Table S4. Baseline characteristics of included studies.
Authors [year] (Ref.) | Language | Origin | Study design | Study period | NOS | Categories | No. samples | Mean age (years) | Histological subtypes | Stages | Material | Detection | Positive site | Cut-off value | Outcomes | Extractions | Analysis | Endpoint | Follow-up (months) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CP features | Prognosis | Total | PE | NE | AC | SCC | Others | ||||||||||||||||||
Chen et al. [2013] (18) | English | Taiwan | ROS | 2004–2009 | 8 | × | √ | 20 | 18 | 2 | 70.4 | 20 | – | – | III–IV | Paraffin embedded tissue | IHC | NI | 10% staining | HR | Reported | U | OS | 60 | |
Chen et al. [2012] (13) | English | China mainland | ROS | 2003–2004 | 8 | √ | √ | 113 | 57 | 56 | 57.2 | 58 | 52 | 3 | I–IV | Paraffin embedded tissue | IHC | Nucleus | Median histoscore | OR, HR | DDE | U | OS | 60 | |
Chiou et al. [2010] (19) | English | Taiwan | ROS | NI | 7 | × | √ | 118 | 78 | 40 | 58.8 | 118 | – | – | I–IV | Paraffin embedded tissue | IHC | NI | NI | HR | DDE | U | OS | 80 | |
Dong et al. [2013] (33) | Chinese | China mainland | ROS | 2009–2012 | 7 | √ | × | 60 | 37 | 23 | 68.0 | 17 | 43 | – | I–IV | Paraffin embedded tissue | IHC | Nucleus | 25% staining | OR | DDE | U | – | – | |
Li et al. [2016] (14] | English | China mainland | ROS | 2013–2014 | 7 | √ | × | 65 | 38 | 27 | 53.0 | NI | NI | NI | I–IV | Paraffin embedded tissue | IHC | Membrane | 25% staining | OR | DDE | U | – | – | |
Li et al. [2012] (15) | English | China mainland | ROS | 2008–2011 | 7 | √ | √ | 44 | 24 | 20 | 62.6 | 23 | 21 | – | I–IV | Paraffin embedded tissue | IHC | Nucleus | 10% staining | OR, HR | DDE | U | OS | 12 | |
Li et al. [2013] (16) | English | China mainland | ROS | 2004–2007 | 8 | √ | √ | 102 | 29 | 73 | NI | 60 | 42 | – | I–IV | Paraffin embedded tissue | IHC | Nucleus | 25% staining | OR, HR | DDE | U | OS | 60 | |
Ni et al. [2012] (34) | Chinese | China mainland | ROS | 2007–2009 | 7 | √ | × | 50 | 21 | 29 | 53.0 | 18 | 29 | 3 | I–IV | Paraffin embedded tissue | IHC | Nucleus | 20% staining | OR | DDE | U | – | – | |
Qiao et al. [2012] (35) | Chinese | China mainland | ROS | 2003–2009 | 7 | √ | × | 40 | 15 | 25 | NI | 19 | 21 | – | I–III | Paraffin embedded tissue | IHC | Nucleus | 5% staining | OR | DDE | U | – | – | |
Sun et al. [2012] (36) | Chinese | China mainland | ROS | 2008–2010 | 6 | √ | × | 186 | 87 | 99 | 55.0 | 81 | 105 | – | I–IV | Paraffin embedded tissue | IHC | Cytoplasm | NI | OR | DDE | U | – | – | |
Tang et al. [2015] (17) | English | Taiwan | ROS | NI | 9 | √ | √ | 133 | 92 | 41 | NI | 97 | 22 | 14 | I–IV | Paraffin embedded tissue | IHC | NI | 50% staining | OR, HR | DDE, reported | U & M | OS | 120 | |
Wei et al. [2011] (37) | Chinese | China mainland | ROS | 2002–2005 | 8 | × | √ | 51 | 27 | 24 | 55.0 | NI | NI | NI | I–IV | Paraffin embedded tissue | IHC | Nucleus | 0% staining | HR | DDE | U | OS | 98 | |
Xiang et al. [2015] (38) | Chinese | China mainland | ROS | 2010–2013 | 7 | √ | × | 60 | 43 | 17 | 53.9 | 20 | 30 | 10 | I–IV | Paraffin embedded tissue | IHC | Nucleus | 50% staining | OR | DDE | U | – | – | |
Yang et al. [2014] (39) | Chinese | China mainland | ROS | 2008–2013 | 7 | √ | × | 60 | 36 | 24 | 61.0 | 23 | 37 | – | I–IV | Paraffin embedded tissue | IHC | NI | 10% staining | OR | DDE | U | – | – | |
Zhang et al. [2013] (40) | Chinese | China mainland | ROS | 2005–2006 | 9 | √ | √ | 126 | 52 | 74 | NI | NI | NI | NI | I–IV | Paraffin embedded tissue | IHC | NI | 1% staining | OR, HR | DDE, reported | U & M | OS | 90 | |
Zhou et al. [2011] (41) | Chinese | China mainland | ROS | 2000–2010 | 6 | √ | × | 135 | 44 | 91 | 60.0 | 70 | 49 | 16 | I–IV | Paraffin embedded tissue | IHC | Nucleus | NI | OR | DDE | U | – | – |
AC, adenocarcinoma; CP, clinicopathological; DDE, demographic data extrapolated; HR, hazard ratio; IHC, immunohistochemistry; M, multivariate; NE, negative expression; NI, no information; OR, odds ratio; OS, overall survival; PE, positive expression; ROS, retrospective observational study; U, univariate.